Relay Therapeutics, Inc. (RLAY) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
20/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinRLAY / S&P 88.04% / 15.20% |
WinRLAY / S&P 23.86% / 15.00% |
LoseRLAY / S&P -18.75% / 50.40% |
| 2026-Q12/3 |
WinRLAY / S&P 17.61% / -4.33% |
WinRLAY / S&P 39.04% / 11.30% |
LoseRLAY / S&P -29.09% / 27.70% |
| 2025-Q42/3 |
WinRLAY / S&P 62.07% / 2.65% |
WinRLAY / S&P 53.45% / 9.00% |
LoseRLAY / S&P -31.78% / 13.40% |
| 2025-Q31/3 |
WinRLAY / S&P 50.87% / 8.12% |
LoseRLAY / S&P -16.49% / 4.61% |
LoseRLAY / S&P -34.10% / 13.45% |
| 2025-Q21/3 |
WinRLAY / S&P 32.06% / 10.94% |
LoseRLAY / S&P -76.27% / 4.83% |
LoseRLAY / S&P -23.81% / 10.63% |
| 2025-Q10/3 |
LoseRLAY / S&P -36.41% / -4.27% |
LoseRLAY / S&P -78.26% / 4.98% |
LoseRLAY / S&P -16.67% / 10.57% |
| 2024-Q40/3 |
LoseRLAY / S&P -41.81% / 2.41% |
LoseRLAY / S&P -60.83% / 5.25% |
LoseRLAY / S&P -15.71% / 6.15% |
| 2024-Q31/3 |
WinRLAY / S&P 8.59% / 5.89% |
LoseRLAY / S&P -61.22% / 5.89% |
LoseRLAY / S&P -2.61% / 6.11% |
| 2024-Q21/3 |
LoseRLAY / S&P -21.45% / 4.28% |
WinRLAY / S&P 3637.58% / 5.38% |
LoseRLAY / S&P -13.10% / 5.12% |
| 2024-Q11/3 |
LoseRLAY / S&P -24.61% / 10.56% |
WinRLAY / S&P 2873.65% / 5.71% |
LoseRLAY / S&P -5.71% / 5.59% |
| 2023-Q43/3 |
WinRLAY / S&P 30.92% / 11.69% |
WinRLAY / S&P 1749.82% / 6.81% |
WinRLAY / S&P 8.11% / 7.78% |
| 2023-Q32/3 |
LoseRLAY / S&P -33.04% / -3.27% |
WinRLAY / S&P 1422.12% / 7.52% |
WinRLAY / S&P 0.75% / -5.03% |
| 2023-Q21/3 |
LoseRLAY / S&P -23.74% / 8.74% |
LoseRLAY / S&P -53.30% / 9.50% |
WinRLAY / S&P 13.28% / -8.57% |
| 2023-Q11/3 |
WinRLAY / S&P 10.24% / 7.50% |
LoseRLAY / S&P -52.40% / 10.77% |
LoseRLAY / S&P RLAY unavailable / -15.69% |
| 2022-Q40/3 |
LoseRLAY / S&P -33.21% / 7.56% |
LoseRLAY / S&P -54.41% / 11.88% |
LoseRLAY / S&P RLAY unavailable / -17.99% |
| 2022-Q31/3 |
WinRLAY / S&P 33.55% / -4.88% |
LoseRLAY / S&P RLAY unavailable / 13.47% |
LoseRLAY / S&P RLAY unavailable / -1.41% |
| 2022-Q20/3 |
LoseRLAY / S&P -44.04% / -16.10% |
LoseRLAY / S&P RLAY unavailable / 13.71% |
LoseRLAY / S&P RLAY unavailable / 11.04% |
| 2022-Q11/3 |
WinRLAY / S&P -2.54% / -4.60% |
LoseRLAY / S&P RLAY unavailable / 15.97% |
LoseRLAY / S&P RLAY unavailable / 42.23% |
| 2021-Q40/3 |
LoseRLAY / S&P -2.60% / 11.03% |
LoseRLAY / S&P RLAY unavailable / 15.00% |
LoseRLAY / S&P RLAY unavailable / 96.40% |
| 2021-Q30/3 |
LoseRLAY / S&P -13.83% / 0.58% |
LoseRLAY / S&P RLAY unavailable / 10.77% |
LoseRLAY / S&P RLAY unavailable / 69.42% |
| 2021-Q20/3 |
LoseRLAY / S&P 5.84% / 8.55% |
LoseRLAY / S&P RLAY unavailable / 6.58% |
LoseRLAY / S&P RLAY unavailable / 51.81% |
| 2021-Q10/3 |
LoseRLAY / S&P -16.82% / 6.17% |
LoseRLAY / S&P RLAY unavailable / -1.06% |
LoseRLAY / S&P RLAY unavailable / 7.39% |
| 2020-Q40/3 |
LoseRLAY / S&P -2.42% / 12.15% |
LoseRLAY / S&P RLAY unavailable / -3.72% |
LoseRLAY / S&P RLAY unavailable / -33.42% |
| 2020-Q30/3 |
LoseRLAY / S&P RLAY unavailable / 8.93% |
LoseRLAY / S&P RLAY unavailable / -2.04% |
LoseRLAY / S&P RLAY unavailable / -27.10% |
| 2020-Q20/3 |
LoseRLAY / S&P RLAY unavailable / 20.54% |
LoseRLAY / S&P RLAY unavailable / -0.46% |
LoseRLAY / S&P RLAY unavailable / -27.11% |
| 2020-Q10/3 |
LoseRLAY / S&P RLAY unavailable / -19.60% |
LoseRLAY / S&P RLAY unavailable / 3.47% |
LoseRLAY / S&P RLAY unavailable / -14.75% |
| 2019-Q40/3 |
LoseRLAY / S&P RLAY unavailable / 9.07% |
LoseRLAY / S&P RLAY unavailable / 5.36% |
LoseRLAY / S&P RLAY unavailable / 2.99% |
| 2019-Q30/3 |
LoseRLAY / S&P RLAY unavailable / 1.70% |
LoseRLAY / S&P RLAY unavailable / 5.02% |
LoseRLAY / S&P RLAY unavailable / 0.21% |
| 2019-Q20/3 |
LoseRLAY / S&P RLAY unavailable / 4.30% |
LoseRLAY / S&P RLAY unavailable / 6.64% |
LoseRLAY / S&P RLAY unavailable / 8.65% |
| 2019-Q10/3 |
LoseRLAY / S&P RLAY unavailable / 13.65% |
LoseRLAY / S&P RLAY unavailable / 8.12% |
LoseRLAY / S&P RLAY unavailable / 14.29% |
| 2018-Q40/3 |
LoseRLAY / S&P RLAY unavailable / -13.52% |
LoseRLAY / S&P RLAY unavailable / 9.05% |
LoseRLAY / S&P RLAY unavailable / 18.23% |
| 2018-Q30/3 |
LoseRLAY / S&P RLAY unavailable / 7.71% |
LoseRLAY / S&P RLAY unavailable / 10.21% |
LoseRLAY / S&P RLAY unavailable / 19.06% |
| 2018-Q20/3 |
LoseRLAY / S&P RLAY unavailable / 3.43% |
LoseRLAY / S&P RLAY unavailable / 9.03% |
LoseRLAY / S&P RLAY unavailable / 14.46% |
| 2018-Q10/3 |
LoseRLAY / S&P RLAY unavailable / -0.76% |
LoseRLAY / S&P RLAY unavailable / 7.68% |
LoseRLAY / S&P RLAY unavailable / 12.46% |
| 2017-Q40/3 |
LoseRLAY / S&P RLAY unavailable / 6.64% |
LoseRLAY / S&P RLAY unavailable / 7.03% |
LoseRLAY / S&P RLAY unavailable / 13.82% |
| 2017-Q30/3 |
LoseRLAY / S&P RLAY unavailable / 4.48% |
LoseRLAY / S&P RLAY unavailable / 5.68% |
LoseRLAY / S&P RLAY unavailable / 17.57% |
| 2017-Q20/3 |
LoseRLAY / S&P RLAY unavailable / 3.09% |
LoseRLAY / S&P RLAY unavailable / 4.83% |
LoseRLAY / S&P RLAY unavailable / 17.74% |
| 2017-Q10/3 |
LoseRLAY / S&P RLAY unavailable / 6.07% |
LoseRLAY / S&P RLAY unavailable / 3.67% |
LoseRLAY / S&P RLAY unavailable / 13.32% |
| 2016-Q40/3 |
LoseRLAY / S&P RLAY unavailable / 3.82% |
LoseRLAY / S&P RLAY unavailable / 2.09% |
LoseRLAY / S&P RLAY unavailable / 7.05% |
| 2016-Q30/3 |
LoseRLAY / S&P RLAY unavailable / 3.85% |
LoseRLAY / S&P RLAY unavailable / 0.20% |
LoseRLAY / S&P RLAY unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | RLAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 440.95% | 20.78% |
| Annualized return | 440.95% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | RLAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -39.31% | 83.14% |
| Annualized return | -9.51% | 12.86% |
10Y · 2020-07-16 to 2026-08-27
| Metric | RLAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -44.59% | 319.30% |
| Annualized return | -5.73% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |